Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid. [electronic resource]
- JAMA dermatology 10 2018
- 1225-1226 p. digital
Publication Type: Case Reports; Letter
2168-6084
10.1001/jamadermatol.2018.2526 doi
Aged, 80 and over Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Dermatologic Agents--therapeutic use Humans Male Pemphigoid, Bullous--drug therapy